Curcumin-glucoside, A Novel Synthetic Derivative of Curcumin, Inhibits -Synuclein Oligomer Formation: Relevance to Parkinson's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|1|76-84

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.1, 2012-01, pp. : 76-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease

By  

Current Pharmaceutical Design, Vol. 18, Iss. 1, 2012-01 ,pp. : 91-99

Bentham Science Publishers

Access to resources Recommend Favorite

A synthetic curcumin derivative hydrazinobenzoylcurcumin induces autophagy in A549 lung cancer cells

By Zhou Guang-Zhou   Zhang Shuai-Na   Zhang Lu   Sun Gang-Chun   Chen Xiao-Bing  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 52, Iss. 1, 2014-01 ,pp. : 111-116

Informa Healthcare

Access to resources Recommend Favorite

Improved Pharmacokinetic Profile and Anti-Inflammatory Property of a Novel Curcumin Derivative, A50

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 6, 2013-07 ,pp. : 535-542

Bentham Science Publishers

Access to resources Recommend Favorite

-Synuclein Ubiquitination and Novel Therapeutic Targets for Parkinson’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 4, 2014-06 ,pp. : 630-637

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic Curcumin Analog UBS109 Inhibits the Growth of Head and Neck Squamous Cell Carcinoma Xenografts

By  

Current Cancer Drug Targets, Vol. 14, Iss. 4, 2014-05 ,pp. : 380-393

Bentham Science Publishers

Access to resources Recommend Favorite